UBS Group’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $271K | Buy |
209,701
+38,105
| +22% | +$63K | ﹤0.01% | 6462 |
|
|
2025
Q4 | $379K | Buy |
171,596
+90,304
| +111% | +$170K | ﹤0.01% | 6242 |
|
|
2025
Q3 | $132K | Sell |
81,292
-194,603
| -71% | -$407K | ﹤0.01% | 6938 |
|
|
2025
Q2 | $715K | Buy |
275,895
+192,833
| +232% | +$761K | ﹤0.01% | 5721 |
|
|
2025
Q1 | $559K | Sell |
83,062
-118,776
| -59% | -$841K | ﹤0.01% | 5760 |
|
|
2024
Q4 | $1.37M | Buy |
201,838
+180,665
| +853% | +$1.19M | ﹤0.01% | 5066 |
|
|
2024
Q3 | $176K | Sell |
21,173
-1,462
| -6% | -$10.6K | ﹤0.01% | 5969 |
|
|
2024
Q2 | $144K | Sell |
22,635
-24,705
| -52% | -$190K | ﹤0.01% | 5902 |
|
|
2024
Q1 | $439K | Buy |
47,340
+13,665
| +41% | +$160K | ﹤0.01% | 5300 |
|
|
2023
Q4 | $429K | Buy |
33,675
+9,624
| +40% | +$100K | ﹤0.01% | 5220 |
|
|
2023
Q3 | $248K | Sell |
24,051
-2,226
| -8% | -$25.8K | ﹤0.01% | 5208 |
|
|
2023
Q2 | $344K | Sell |
26,277
-1,498
| -5% | -$18.3K | ﹤0.01% | 5118 |
|
|
2023
Q1 | $311K | Buy |
27,775
+14,986
| +117% | +$148K | ﹤0.01% | 5055 |
|
|
2022
Q4 | $108K | Sell |
12,789
-391
| -3% | -$3.72K | ﹤0.01% | 6031 |
|
|
2022
Q3 | $220K | Buy |
13,180
+4,685
| +55% | +$86.3K | ﹤0.01% | 5007 |
|
|
2022
Q2 | $125K | Sell |
8,495
-4,538
| -35% | -$93.5K | ﹤0.01% | 5254 |
|
|
2022
Q1 | $324K | Sell |
13,033
-2,142
| -14% | -$55.3K | ﹤0.01% | 5007 |
|
|
2021
Q4 | $486K | Buy |
15,175
+11,895
| +363% | +$434K | ﹤0.01% | 5009 |
|
|
2021
Q3 | $118K | Buy |
3,280
+3,000
| +1,071% | +$118K | ﹤0.01% | 5712 |
|
|
2021
Q2 | $12K | Sell |
280
-4,254
| -94% | -$185K | ﹤0.01% | 7889 |
|
|
2021
Q1 | $207K | Buy |
4,534
+2,455
| +118% | +$141K | ﹤0.01% | 5461 |
|
|
2020
Q4 | $143K | Buy |
+2,079
| New | +$102K | ﹤0.01% | 5462 |
|
Other funds holding LUNG
SCM
ECM
VCM
